Skip to content

Antimicrobial therapy in the surgical treatment of peri-implantitis

Adjunctive systemic antimicrobial therapy in the surgical treatment of peri-implantitis. A prospective randomized clinical study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2017-002532-16-BE
Enrollment
30
Registered
2017-08-07
Start date
2017-12-05
Completion date
Unknown
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To treat patients with chronic infection of dental implants. One group with antibiotics and one group without.

Interventions

Trade Name: Amoxicilline Product Name: Clamoxyl Pharmaceutical Form: Pillules Trade Name: Metronidazole Product Name: Flagyl Pharmaceutical Form: Pillules

Sponsors

Cliniques Universitaires Saint-Luc
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - one or more bleeding lesions in patients with chronic infection of dental implants. - Dutch Periodontal Screening Index from 0 to 2 - Full Mouth Plaque Score inferior or equal to 25% Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range 10

Exclusion criteria

Exclusion criteria: - smokers - pregnant and nursing women - patients with another parodontal disease excepted chronic infection of dental implants - systemic inflammatory disease (only based with clinical examination) - antibiotic in the previous 3 months

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate the influence of the administration of antibiotics on the surgical treatment for chronic infection of dental implants.;Secondary Objective: Not applicable;Primary end point(s): - Measurement of dental plaque, gingival index, suppuration of sondage, depth of sondage, gingival recession.;Timepoint(s) of evaluation of this end point: The measurements will be done at first month, at 3 month and at 6 month

Secondary

MeasureTime frame
Secondary end point(s): not applicable;Timepoint(s) of evaluation of this end point: not applicable

Countries

Belgium

Contacts

Public ContactDorian Gaudy

Cliniques Universitaires Saint-Luc

dorian.gaudy@uclouvain.be0032027645719

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026